How will Biosecure Act impact Indian pharma companies? Aditya Khemka explains Leave a Comment / In the News / Sushant Khot How will Biosecure Act impact Indian pharma companies? Aditya Khemka explains Read More »
AIF Demand Signals Focus On Wealth Creation Leave a Comment / In the News / Sushant Khot AIF Demand Signals Focus On Wealth Creation Read More »
As pharma crawls back into spotlight, here are Aditya Khemka’s tips for spotting value investments Leave a Comment / In the News / Sushant Khot As pharma crawls back into spotlight, here are Aditya Khemka’s tips for spotting value investments Read More »
Investors’ Focus To Shift To Value-Driven Opportunities In Healthcare Sector: InCred’s Aditya Khemka Leave a Comment / In the News / Sushant Khot Investors’ Focus To Shift To Value-Driven Opportunities In Healthcare Sector: InCred’s Aditya Khemka Read More »
ETMarkets PMS Talk: 9 high-conviction stocks deliver up to 300% returns in Emerging Business Fund: Aditya Sood Leave a Comment / In the News / Sushant Khot ETMarkets PMS Talk: 9 high-conviction stocks deliver up to 300% returns in Emerging Business Fund: Aditya Sood Read More »
At $51 billion, sell-downs rise over 88 per cent YTD in 2024 Leave a Comment / In the News / Sushant Khot At $51 billion, sell-downs rise over 88 per cent YTD in 2024 Read More »
Hot Mkt Prompts InCred to Shut Multi-cap AIF, Return Money Leave a Comment / In the News / Sushant Khot Hot Mkt Prompts InCred to Shut Multi-cap AIF, Return Money Read More »
Hot Mkt Prompts InCred to Shut Multi-cap AIF, Return Money Leave a Comment / In the News / Sushant Khot Hot Mkt Prompts InCred to Shut Multi-cap AIF, Return Money Read More »
Hospitals Vs Diagnostics: Stocks surge up to 250%, but which segment is better to invest in Leave a Comment / In the News / Sushant Khot Hospitals Vs Diagnostics: Stocks surge up to 250%, but which segment is better to invest in Read More »
Private credit booms but mispricing of risk a key concern Leave a Comment / In the News / Sushant Khot Private credit booms but mispricing of risk a key concern Read More »
